Mechanism of 5-Amino-1MQ and JBSNF in Enhancing NAD+, Energy Metabolism, and Muscle Regeneration

by Dr. James Ross

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law.

Age-Related Muscle Decline

With advancing age, skeletal muscle progressively loses mass and strength. This deterioration is compounded by a reduced ability of muscle stem cells (satellite cells) to proliferate, differentiate, and fuse into myofibers after injury. As a result, older adults experience impaired recovery, heightened risk of sarcopenia, and increased likelihood of disability and morbidity.

Role of Muscle Stem Cells in Repair

Satellite cells are the primary mediators of skeletal muscle regeneration. They transition from quiescence to proliferation, generate fusion-competent myoblasts, and restore injured fibers. Aging disrupts this process through diminished stem cell activity, cellular senescence, and reduced stem cell abundance, leading to inefficient repair.

NAD+ Decline as a Central Factor

Nicotinamide adenine dinucleotide (NAD+) is critical for mitochondrial function, cellular energy metabolism, and redox balance. NAD+ levels decline with age, contributing to altered muscle bioenergetics and reduced regenerative potential. Restoring NAD+ availability has been shown in animal models to improve muscle repair and stem cell activity.

NNMT and Its Impact on Muscle Aging

Nicotinamide N-methyltransferase (NNMT) is an enzyme that consumes nicotinamide, a key NAD+ precursor. Overexpression of NNMT in aging skeletal muscle impairs NAD+ salvage, reduces sirtuin activity, and promotes stem cell dysfunction. Elevated NNMT has been consistently observed in aged muscle and is strongly associated with sarcopenia.

Inhibition of NNMT as a Therapeutic Strategy

Pharmacological blockade of NNMT prevents nicotinamide depletion and restores NAD+ availability. In preclinical studies, small-molecule NNMT inhibitors significantly improved muscle stem cell proliferation and fusion. This led to larger regenerated fibers, greater contractile strength, and enhanced recovery after injury in aged mice.

Experimental Evidence

• Regeneration: NNMT inhibition nearly doubled the cross-sectional area of regenerated fibers and increased the proportion of larger myofibers. 
• Strength: Peak torque in treated animals rose by ~70% compared with controls, indicating meaningful functional gains. 
• Safety: Repeated dosing showed no systemic toxicity, with stable liver, kidney, and metabolic markers. 
• Cellular Effects: In vitro, NNMT inhibition enhanced myoblast differentiation and normalized NAD+/NADH balance.

5-Amino-1MQ and JBSNF-000088

Two leading NNMT inhibitors—5-amino-1MQ and JBSNF-000088—demonstrate potent activity across cell and animal models.

• 5-Amino-1MQ reduces intracellular 1-methylnicotinamide levels, restoring NAD+ metabolism and promoting healthier energy balance in muscle and fat cells. 
• JBSNF-000088, a nicotinamide analog, suppresses NNMT activity, improves glucose utilization, enhances insulin sensitivity, and lowers body weight in obese mice.

Implications for Aging Muscle

By suppressing NNMT, these compounds rejuvenate stem cell function, accelerate muscle regeneration, and restore strength. The therapy effectively re-establishes a youthful regenerative profile in aged skeletal muscle without evident toxicity, highlighting NNMT inhibitors as promising candidates for combating age-related muscle decline and sarcopenia.

Know about  : what are amino acids

REFERENCES

1. Neelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem Pharmacol. 2018 Jan;147:141-152. doi: 10.1016/j.bcp.2017.11.007. Epub 2017 Nov 15. PMID: 29155147; PMCID: PMC5826726.
2. Kannt, A., Rajagopal, S., Kadnur, S.V. et al. A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders. Sci Rep 8, 3660 (2018). https://doi.org/10.1038/s41598-018-22081-7
3. Neelakantan H, Brightwell CR, Graber TG, Maroto R, Wang HL, McHardy SF, Papaconstantinou J, Fry CS, Watowich SJ. Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochem Pharmacol. 2019 May;163:481-492. doi: 10.1016/j.bcp.2019.02.008. Epub 2019 Feb 10. PMID: 30753815; PMCID: PMC6469996.

Product available for research use only: